Social Pulse: Johnson & Johnson (JNJ)
JNJ on New York Consolidated
86.82USD
24 May 2013
86.82USD
24 May 2013
Price Change (% chg)
$-0.39 (-0.45%)
$-0.39 (-0.45%)
Prev Close
$87.21
$87.21
Open
$86.80
$86.80
Day's High
$87.03
$87.03
Day's Low
$86.49
$86.49
Volume
10,390,046
10,390,046
Avg. Vol
9,889,328
9,889,328
52-wk High
$89.99
$89.99
52-wk Low
$61.71
$61.71
- Is Blue-Chip Dividend Investing Only For Rich People?
- Recession Is Coming
- Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback
- Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Rates
- A Moderate-Risk, High-Reward Dividend Play
- Equities Can Rise Another 5%-10% On Bernanke's Comments
Press Releases
- Noble Financial Capital Markets Appoints Healthcare Scientific Advisory Board
- CEO Alex Gorsky Elected Chairman of Johnson & Johnson; Bill Weldon To Step Down After 41-year Career at Johnson & Johnson
- INCRAFT AAA Stent-Graft System One-Year Follow-Up Data Presented at 2012 Veith Symposium
- Health Care Executive, Scholar and Vice Chancellor from UCLA, Dr. A. Eugene Washington, Appointed to Johnson & Johnson Board of Directors
- S.M.A.R.T.® Vascular Stent Systems Receive FDA Approval for Use in SFA
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
